or
forgot password
  • cancer clinical trials in sioux city, IA

  • Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Siouxland Hematology - Oncology Associates
    Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma
    Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Siouxland Hematology Oncology Associates
    Sioux City, Iowa 51101
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Recurrent Esophageal Cancer, Squamous Cell Carcinoma of the Esophagus, Stage IV Esophageal Cancer
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Siouxland Hematology Oncology Associates
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Siouxland Hematology Oncology Associates
    Sioux City, Iowa 51101
    Light Chain Deposition Disease, Smoldering Multiple Myeloma
    Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
    Siouxland Hematology Oncology Associates
    Sioux City, Iowa 51101
    Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Stage IB Esophageal Cancer, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer, Stage IIIA Esophageal Cancer, Stage IIIB Esophageal Cancer
    Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Diarrhea, Gastrointestinal Complications, Unspecified Adult Solid Tumor, Protocol Specific
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Siouxland Hematology Oncology Associates
    Sioux City, Iowa 51101
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Lymphoma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Saint Luke's Regional Medical Center

    Trial Locations
    Saint Luke's Regional Medical Center
    Siouxland Hematology Oncology Associates
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
    Siouxland Hematology Oncology Associates
    Sioux City, Iowa 51101
    Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Childhood Supratentorial Primitive Neuroectodermal Tumor, Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Extraosseous Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Peripheral Primitive Neuroectodermal Tumor of the Kidney, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Prostate Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Breast Cancer
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Siouxland Hematology Oncology Associates
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Siouxland Hematology Oncology Associates
    Sioux City, Iowa 51101
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Siouxland Hematology Oncology Associates
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Breast Cancer, Depression, Fatigue, Sleep Disorders
    Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
    Siouxland Hematology Oncology Associates
    Sioux City, Iowa 51101
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Siouxland Hematology-Oncology Associates, LLP
    Sioux City, Iowa 51101
    Head and Neck Cancer, Precancerous Condition
    PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
    Siouxland Hematology-Oncology Associates, LLP
    Sioux City, Iowa 51101
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Mercy Medical Center-Sioux City

    Trial Locations
    Mercy Medical Center-Sioux City
    Saint Luke's Regional Medical Center
    Siouxland Hematology Oncology Associates
    Colorectal Neoplasms
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    St. Luke's Regional Medical Center
    Sioux City, Iowa 51104
    Lymphoma
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    St. Luke's Regional Medical Center
    Cancer
    Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
    Mercy Medical Center - Sioux City

    Trial Locations
    Mercy Medical Center - Sioux City
    Siouxland Hematology-Oncology Associates, LLP
    Lymphoma, Neurotoxicity, Therapy-related Toxicity